PPI network analysis results suggest that the core targets of ECXB formula for the treatment of COPD mainly include MAPK8, ESR1, TP53, MAPK3, JUN, RELA, MAPK1, and AKT1. The gene discussed is ESR1; the disease is chronic obstructive pulmonary disease.